Precision Medicine and immunomodulatory therapy for Stevens Johnson Syndrome/Toxic Epidermal Necrolysis

Omer Iqbal

Loyola University Medical Center

Omer Iqbal, MD, FACC, FESC. is a Professor of Pathology and Ophthalmology at Loyola University Medical Center in Maywood, Illinois, USA.  He is an elected fellow in the American College of Cardiology and European Society of Cardiology.  For three decades he has been involved in research in Hemostasis and Thrombosis.  His scientific interests are wide and varied including Stevens Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), and Precision Medicine. He is a member of numerous national and international scientific organizations including ISTH, IUA, ASH, AHA, ACC, ESC and ASCO.  He has authored and co-authored over 100 publications and 16 book chapters.


Stevens Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) is a rare but fatal immune-mediated Severe Cutaneous Adverse Reaction (SCAR) which is often drug-induced frequently involving the eyes leading to corneal blindness.... [ view full abstract ]


  1. Omer Iqbal (Loyola University Medical Center)

Topic Area

Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, et


OS2b-A » Personalized therapies (15:15 - Tuesday, 26th June, Amphitheater)

Presentation Files

The presenter has not uploaded any presentation files.